IP Verse

Methods And Systems For Purifying Non-Complexed Botulinum Neurotoxin

PatentPatent Analysis

EP2490986

REVANCE THERAPEUTICS
Application Number
EP10825598A
Filing Date
Oct 20, 2010
Status
Patent Maintained As Amended
Mar 22, 2024
Grant Date
Apr 24, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3368071B1
EP2661276B1

Bibliography

The patent EP2490986B2 was granted to Revance Therapeutics on Apr 24, 2024 following the initial filing on Oct 20, 2010 under the application number EP10825598A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

WACHTERSHAUSER & HARTZ PATENTANWALTSPARTNERSCHAFT MBB BLODIGMay 2, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents